ENT Section

ENT1


Board 2019-2021


  Ludger Klimek

Section Chair
Ludger Klimek
Germany

Section Secretary
Sanna Toppila-Salmi

Past Chair
Philippe Gevaert

Board members
Cemal Cingi
Valerie Hox
Carmen Milagros Rondon
Michele Schiappoli
Peter Tomazic

JM Representative
Aspasia Karavelia

 


-



Interview with Philippe Gevaert, Ghent University

 

Philippe Gevaert talks about the importance of interaction
between ENT specialists and immunotherapy and biologics
specialists, and highlights the importance of understanding
who to treat with these medications.



”It is crucial to take a good product for the right patient and to
tailor it for the patient itself. Precision medicine (...) is about
combining the needs of the patient"

June 2019

 









-









Relevant literature


Auge et al - EAACI position paper on standardization of nasal allergen challenges

Roberts et al - EAACI Guidelines on allergen immunotherapy: Allergic rhinoconjunctivitis

Hellings et al - Non-allergic rhinitis: Position paper of the European Academy of Allergy and Clinical Immunology

Hellings et al - Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis - A EUROREA-ARIA-EPOS-AIRWAYS ICP statement

Pfaar et al - Defining pollen exposure times for clinical trials of allergen immunotherapy for pollen-induced rhinoconjunctivitis - an EAACI position paper

 

Last updated 14 November 2019
Privacy Policy - disclaimer

EAACI recently updated its privacy policy and would like to highlight some key bits of information with you.

  • EAACI does not distribute, share or sell your information;
  • For technical and administrative purposes some information that can be used to identify you may be forwarded to third parties. For example, to process your registration for the EAACI Annual Congress and other EAACI events;
  • The Academy may also send you e-mail messages with news from the society. If you would like to no longer receive them, you can unsubscribe at any time by using the unsubscribe link in any of our communications;
  • You may also update your preferences or your profile information at any time by contacting us.

To continue please confirm that you agree with our updated privacy policy.

Thank you!

You have successfully agreed the new privacy policy – disclaimer.

Thank you!

You disagreed with the new privacy policy – disclaimer and your feedback will be reviewed as soon as possible.

Agree & Continue
Disagree
Send feedback
Cancel